Equillium Historical Income Statement

EQ Stock  USD 2.06  0.38  15.57%   
Historical analysis of Equillium income statement accounts such as Selling General Administrative of 10.3 M can show how well Equillium performed in making a profits. Evaluating Equillium income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Equillium's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Equillium latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Equillium is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

About Equillium Income Statement Analysis

Equillium Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Equillium shareholders. The income statement also shows Equillium investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Equillium Income Statement Chart

Equillium Income Statement is one of the three primary financial statements used for reporting Equillium's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Equillium revenue and expense. Equillium Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Equillium's Interest Income is relatively stable compared to the past year. As of 03/28/2024, Interest Expense is likely to grow to about 748.9 K, while Net Loss is likely to drop (8.6 M).

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Equillium. It is also known as Equillium overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Equillium's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Equillium current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.At this time, Equillium's Interest Income is relatively stable compared to the past year. As of 03/28/2024, Interest Expense is likely to grow to about 748.9 K, while Net Loss is likely to drop (8.6 M).
 2021 2022 2023 2024 (projected)
Other Operating Expenses37.8M54.8M50.6M38.1M
Depreciation And Amortization72K46.1M53.0M55.7M

Equillium income statement Correlations

0.370.030.18-0.520.430.410.090.760.120.810.710.450.00.440.42
0.37-0.89-0.81-0.970.980.99-0.870.38-0.790.790.710.98-0.660.930.82
0.03-0.890.990.79-0.83-0.851.0-0.150.96-0.51-0.43-0.830.69-0.74-0.73
0.18-0.810.990.69-0.74-0.771.0-0.010.96-0.38-0.31-0.730.67-0.65-0.65
-0.52-0.970.790.69-0.98-0.980.76-0.490.71-0.84-0.84-0.990.55-0.96-0.74
0.430.98-0.83-0.74-0.981.0-0.80.45-0.740.80.761.0-0.610.970.76
0.410.99-0.85-0.77-0.981.0-0.820.43-0.760.80.750.99-0.630.960.78
0.09-0.871.01.00.76-0.8-0.82-0.070.96-0.45-0.39-0.790.68-0.71-0.69
0.760.38-0.15-0.01-0.490.450.43-0.07-0.060.710.560.5-0.20.460.51
0.12-0.790.960.960.71-0.74-0.760.96-0.06-0.35-0.45-0.750.46-0.69-0.53
0.810.79-0.51-0.38-0.840.80.8-0.450.71-0.350.720.8-0.530.730.85
0.710.71-0.43-0.31-0.840.760.75-0.390.56-0.450.720.8-0.040.840.37
0.450.98-0.83-0.73-0.991.00.99-0.790.5-0.750.80.8-0.580.980.75
0.0-0.660.690.670.55-0.61-0.630.68-0.20.46-0.53-0.04-0.58-0.46-0.82
0.440.93-0.74-0.65-0.960.970.96-0.710.46-0.690.730.840.98-0.460.6
0.420.82-0.73-0.65-0.740.760.78-0.690.51-0.530.850.370.75-0.820.6
Click cells to compare fundamentals

Equillium Account Relationship Matchups

Equillium income statement Accounts

201920202021202220232024 (projected)
Interest Income1.4M476K57K420K2.0M2.1M
Interest Expense279K1.1M1.1M1.1M491K748.9K
Selling General Administrative9.1M10.2M11.4M17.2M13.6M10.3M
Gross Profit(23K)(45K)(72K)15.6M36.1M37.9M
Operating Income(26.7M)(29.5M)(37.8M)(62.1M)(14.5M)(15.2M)
Net Income From Continuing Ops(25.6M)(29.8M)(39.1M)(62.4M)(8.2M)(8.6M)
Ebit(26.7M)(29.5M)(37.8M)(62.1M)(55.9M)(53.1M)
Research Development17.6M19.4M26.4M37.5M37.0M22.7M
Cost Of Revenue23K45K72K118K135.7K142.5K
Total Operating Expenses26.7M29.5M37.8M54.8M50.6M33.0M
Income Before Tax(25.6M)(29.8M)(39.1M)(62.4M)(12.8M)(13.4M)
Total Other Income Expense Net1.1M(265K)(1.3M)(352K)1.8M1.9M
Net Income Applicable To Common Shares(25.6M)(29.8M)(39.1M)(62.4M)(56.2M)(53.4M)
Net Income(25.6M)(29.8M)(39.0M)(107.7M)(13.3M)(14.0M)
Income Tax Expense(23K)(45K)(72K)45.3M580K551K
Net Interest Income1.1M(623K)(1.0M)(633K)1.3M1.3M
Depreciation And Amortization23K45K72K46.1M53.0M55.7M
Other Operating Expenses26.7M29.5M37.8M54.8M50.6M38.1M
Ebitda(26.7M)(29.5M)(37.7M)(16.0M)(14.5M)(15.2M)
Reconciled Depreciation23K45K72K118K125K71.3K

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

  0.8VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.78MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.77KA Kineta Inc Report 29th of March 2024 PairCorr
  0.76DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
  0.74MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.22)
Revenue Per Share
1.039
Quarterly Revenue Growth
(0.42)
Return On Assets
(0.14)
Return On Equity
(0.49)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.